Moch H
Institut für Pathologie, Universitätsspital Zürich, Schmelzbergstr.12, 8091, Zürich, Schweiz.
Pathologe. 2016 Mar;37(2):127-33. doi: 10.1007/s00292-016-0144-1.
The first S3 guidelines on renal cell cancer cover the practical aspects of imaging, diagnostics and therapy as well as the clinical relevance of pathology reporting. This review summarizes the changes in renal tumor classification and the new recommendations for reporting renal cell tumors. The S3 guidelines recommend the 2016 World Health Organization (WHO) classification of renal cell tumors. Novel renal cell tumor entities and provisional or emerging renal cell tumor entities of the 2016 WHO classification of renal tumors are discussed. The S3 guidelines for renal cell cancer also recommend the use of the WHO/International Society of Urologic Pathology (ISUP) grading system for clear cell and for papillary renal cell carcinomas, which replaces the previously used Fuhrman grading system.
首版关于肾细胞癌的S3指南涵盖了影像学、诊断和治疗的实际方面以及病理报告的临床相关性。本综述总结了肾肿瘤分类的变化以及肾细胞肿瘤报告的新建议。S3指南推荐采用2016年世界卫生组织(WHO)肾细胞肿瘤分类。文中讨论了2016年WHO肾肿瘤分类中的新型肾细胞肿瘤实体以及临时或新兴的肾细胞肿瘤实体。肾细胞癌的S3指南还推荐对透明细胞和乳头状肾细胞癌使用WHO/国际泌尿病理学会(ISUP)分级系统,该系统取代了先前使用的福尔曼分级系统。